Statistics

Total Visits

Views
Open label phase II clinical trial of orteronel (TAK700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013018

Select a period of time:

Number of views in the range

Views
Open label phase II clinical trial of orteronel (TAK700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013015

Views

Views
November 20231
December 20231
January 20242
February 20240
March 20241
April 20240
May 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Ashburn1
Boardman1